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Results The combined incidence of death and amputation (primary
study end-point) was significantly reduced in patients treated with iloprost
(16.0% vs 27.2% in the placebo group; hazard ratio 1.99, 95% confidence
interval 1.05–3.75, p0.03). A statistically significant lower mortality
(6.0%) was reported in patients receiving iloprost, compared to controls
(15.2%) (hazard ratio 2.93, 1.11–7.71, p0.03). The overall incidence of
death and major cardiovascular events was lower in patients receiving
iloprost compared to those assigned placebo (24.0% and 35.9%, respec-
tively), at the limits of statistical significance (relative risk 1.64, 0.97–2.79,
p0.06).
Conclusions These results confirm the poor outcome in elderly pa-
tients with ALLI. Based on a subgroup analysis iloprost, as an adjuvant to
surgery, appears to reduce the combined end-point of death and amputa-
tion.
The Australian Vascular Quality of Life Index (AUSVIQUOL): An
Improved Clinical Quality of Life Tool for Peripheral Vascular Disease
Smith M.J., Borchard K.L.A., Hinton E., Scott A.R.. Eur J Vasc Endovasc
Surg 2007;34:199-205.
Objectives To validate the Australian Vascular Quality of Life Index
(AUSVIQUOL) as a quality of life (QOL) tool appropriate for peripheral
vascular disease patients in the clinical setting.
Design Cross-sectional study.
Materials The study group consisted of 71 patients with vascular
claudication of varying severity attending a tertiary hospital outpatient
department.
Methods The results of the AUSVIQUOL and Medical Outcomes
Short Form Health Survey (SF-36) were compared through factor and
regression analyses. A group of 12 patients was then reassessed to compare
the reliability and internal consistency of the two indices.
Results The AUSVIQUOL took less time to complete than the SF-36
(3.27 v 10.79 min; p0.0001) and fewer patients found the questions
confusing (2% v 26%). The AUSVIQUOL was easier to administer and had
a higher level of patient acceptance than the SF-36. The regression analysis
showed that for each of the domains in the AUSVIQUOL there was a
significant correlation with measures in the SF-36 (adjusted R-squared
0.420, 0.480 and 0.331). The AUSVIQUOL demonstrated a good level of
internal consistency when compared to the SF-36 (Cronbach’s alpha 0.8702
vs 0.6307).
Conclusion In comparison with the SF-36, the AUSVIQUOL is an
improved tool for the QOL assessment of patients with peripheral vascular
disease in the clinical setting.
Prognostic Significance of Declining Ankle-brachial Index Values in
Patients with Suspected or Known Peripheral Arterial Disease
Feringa H.H.H., Karagiannis S.E., Schouten O., Vidakovic R., van Waning
V.H., Boersma E., Welten G., Bax J.J., Poldermans D.. Eur J Vasc Endovasc
Surg 2007;34:206-13.
Background Peripheral arterial disease (PAD) is a risk factor for
cardiovascular events. This study assessed the prognostic significance of
repeated ankle-brachial index (ABI) measurements at rest and after exercise
in patients with PAD receiving conservative treatment.
Methods In a cohort study of 606 patients (mean age 6212 years,
68% male), ABI at rest and after exercise was measured at baseline and after
1 year. Patients with reductions in ABI were divided into three equally-sized
groups (minor, intermediate and major reductions) and were compared to
patients without reductions. During a mean follow-up of 53 years, all-
cause mortality, cardiac events, stroke and progression to kidney failure were
noted.
Results Death was recorded in 83 patients (14%) of which 49% were
due to cardiac causes. Non-fatal myocardial infarction occurred in 38
patients (6%), stroke in 46 (8%) and progression to kidney failure in 35 (6%).
By multivariate analysis, patients with major declines in resting (20%) and
post-exercise (30%) ABI were at increased risk of all-cause mortality (HR:
3.3, 95% CI: 1.5–7.2, HR: 3.0, 95% CI: 1.4–6.4, respectively), cardiac
events (HR: 3.1, 95% CI: 1.3–7.2, HR: 2.4, 95% CI: 1.1–5.6, respectively),
stroke (HR: 4.2, 95% CI: 1.6–10.4, HR: 3.9, 95% CI: 1.4–10.2, respec-
tively) and kidney failure (HR: 2.7, 95% CI: 1.1–7.5, HR: 6.9, 95% CI:
1.5–31.5, respectively), compared to patients with no declines in ABI.
ConclusionsThis study shows that major 1-year declines in resting and
post-exercise ABI are associated with all-cause mortality, cardiac events,
stroke and kidney failure in patients with PAD.
Venous Reflux and Venous Distensibility in Varicose and Healthy
Veins
Jeanneret C., Jäger K.A., Zaugg C.E., Hoffmann U.. Eur J Vasc Endovasc
Surg 2007;34:236-42.
Objectives The aim of this study was to analyse venous diameter
changes and venous reflux parameters, assessed during a standardised Val-
salva manoeuvre in healthy subjects and in patients with varicose veins.
Methods Measurements were carried out in 444 vein segments, (96
legs of 48 healthy volunteers, 52 legs of 35 patients with varicose veins). The
common femoral vein (CVF), the femoral vein (FV) and the great saphenous
vein (GSV) were investigated. The parameters of reflux and the relative
venous diameter change (VD diff %) were measured simultaneously during a
standardised Valsalva manoeuvre.
Results Venous diameter changes during Valsalva manoeuvre (VD
diff) were significantly greater in the GSV and in the deep veins of varicose
patients compared to healthy subjects. The median (Interquartile range) of
VD max in the CFV was: 13.1 (3.5) mm and 11.2 (3.4) mm (p0.0002,
Mann-Whitney - U test), in the FV 7.8 (2.7) mm and 6.9 (2.0) mm
(p0.01, Mann-Whitney), in the GSV: 7.3 (3.7) mm and 4.2 (1.1) mm
(p0.0001, Mann-Whitney) for the varicose and healthy veins respectively.
Good correlation was seen for the retrograde peak reflux velocity (PRV) and
VD diff % in varicose veins (r0.71 (0.57 – 0.81) p0.0001, Mann-
Whitney).
Conclusion Relative venous diameter - changes during a standardised
Valsalvamanoeuvre are significantly larger in the deep and superficial veins of
varicose vein patients compared with healthy veins, the increased distensi-
bility correlates with venous reflux parameters in varicose vein patients.
Readers can access EJVES articles at http://intl.elsevierhealth.com/journals/ejvs/default.cfm
JOURNAL OF VASCULAR SURGERY
August 2007398 Abstracts
